Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 0.90
- Piotroski Score 6.00
- Grade Equal Weight
- Symbol (INOV)
- Company Inovalon Holdings, Inc.
- Price $29.33
- Changes Percentage (-0.08%)
- Change -$0.02
- Day Low $29.33
- Day High $29.33
- Year High $29.65
Inovalon Holdings, Inc. provides cloud-based platforms for data-driven healthcare. It operates Inovalon ONE Platform, a cloud-based platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities. In addition, it offers advisory, implementation, and support services. The company serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. Its platforms include information of data pertaining to approximately 988,000 physicians; 522,000 clinical facilities; and approximately 314 million individuals and 53 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/09/2021
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.00
- Trailing P/E Ratio N/A
- Forward P/E Ratio N/A
- P/E Growth N/A
- Net Income $22.58 M
Income Statement
Quarterly
Annual
Latest News of INOV
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Investors in Mainova (FRA:MNV6) have unfortunately lost 32% over the last three years
Mainova AG (FRA:MNV6) shareholders have seen a 37% drop in share price in three years, worse than market decline. Despite revenue growth, share prices fell, indicating potential disparity. An in-depth...
By Yahoo! Finance | 2 days ago -
Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call Transcript
Inovio Pharmaceuticals discussed progress on DNA medicine platform development in Q3 2024, focusing on INO-3107 for RRP treatment. Positive immunology data, regulatory discussions, and financial disci...
By Yahoo! Finance | 2 weeks ago -
Schroders Capital Global Innovation Trust PLC (LSE:INOV) (Q2 2024) Earnings Call Transcript ...
The earnings call discussed new investments in AI Company II and Neurona Therapeutics, along with the buyback program's impact on NAV discount. The fund sources cash for buybacks by selling liquid hol...
By Yahoo! Finance | 1 month ago
